INTELENCE DIN 02306778
Health Canada record
| Active ingredient(s) | ETRAVIRINE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AG04 ETRAVIRINE |
| Original market date | 27-Mar-2008 |
| Current status date | 27-Mar-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ETRAVIRINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02375931 | INTELENCE | JANSSEN INC | Tablet | ETRAVIRINE 200 MG | Marketed |
| 02396750 | INTELENCE | JANSSEN INC | Tablet | ETRAVIRINE 25 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9436 | 2008-03-27 | New Drug Submission (NDS) |
International API supply for ETRAVIRINE
5 active FDA Drug Master Files.
Request a quote for INTELENCE